Bio-Rad Labs Q1 2025 Earnings Preview
Source: SeekingAlpha
2025-04-30 17:20:04 ET
More on Bio-Rad Labs
- Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript
- Bio-Rad targets 1.5%-3.5% revenue growth in 2025 amid operational improvements and new acquisitions
- Bio-Rad Labs Non-GAAP EPS of $2.90 beats by $0.02, revenue of $667.5M misses by $12.25M
- Seeking Alpha’s Quant Rating on Bio-Rad Labs
- Historical earnings data for Bio-Rad Labs
Read the full article on Seeking Alpha
For further details see:
Bio-Rad Labs Q1 2025 Earnings Preview
Bio-Rad Laboratories Inc. Class A
NASDAQ: BIO
BIO Trading
11.5% G/L:
$277.42 Last:
471,754 Volume:
$274.72 Open:
BIO Latest News
BIO Stock Data
$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules
